Impact of timing of midazolam administration on incidence of postoperative nausea and vomiting in patients undergoing laparoscopic gynecological surgery: A randomized, double-blinded, controlled study

Background A frequently used anxiolytic, midazolam, has recently been recognized for its antiemetic activity during the perioperative period. This study sought to investigate the best time to provide midazolam in order to decrease the frequency of postoperative nausea and vomiting (PONV) without inc...

Full description

Bibliographic Details
Main Authors: Samar Rafik Amin, Taghreed Elshahat Sakr, Shaimaa Ezzat Amin
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Egyptian Journal of Anaesthesia
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/11101849.2022.2132600
_version_ 1797996733876142080
author Samar Rafik Amin
Taghreed Elshahat Sakr
Shaimaa Ezzat Amin
author_facet Samar Rafik Amin
Taghreed Elshahat Sakr
Shaimaa Ezzat Amin
author_sort Samar Rafik Amin
collection DOAJ
description Background A frequently used anxiolytic, midazolam, has recently been recognized for its antiemetic activity during the perioperative period. This study sought to investigate the best time to provide midazolam in order to decrease the frequency of postoperative nausea and vomiting (PONV) without increasing the risk of sedation.Methods A total of 120 women aged 20–60 years who underwent laparoscopic gynecological surgeries were distributed randomly to three groups: group M1 (n = 40) received intravenous 2 mg midazolam 15 min prior anesthesia induction, group M2 (n = 40) received intravenous 2 mg midazolam approximately 30 min prior surgery conclusion, and group C (n = 40) received intravenous normal saline. The frequency of PONV and the rescue antiemetics needs were measured as the primary outcomes during the first 24 hr postoperatively. The secondary outcomes were the severity of nausea, timing of initial emetic attack, time of PACU discharge, patient sedation, and pain scores.Results The frequencies of vomiting and rescue antiemetic use were lower in midazolam groups than controls during early (0–2) and late (0–24) time periods after surgery (P < 0.05), with insignificant difference between M1 and M2 groups. The timing of the first emetic episode was significantly longer in M2 than in C groups (458.3 vs 128.8 minutes) (P < 0.01). Insignificant differences with regard to frequency and severity of nausea, time of PACU discharge, and sedation score were detected among the three groups.Conclusion Midazolam was effective in reducing PONV, whether it was given prior induction of anesthesia or prior end of surgery, without influencing recovery duration or sedation level of the patients.
first_indexed 2024-04-11T10:22:09Z
format Article
id doaj.art-ed87f65dd3834f3398ce50eb10b05396
institution Directory Open Access Journal
issn 1110-1849
language English
last_indexed 2024-04-11T10:22:09Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series Egyptian Journal of Anaesthesia
spelling doaj.art-ed87f65dd3834f3398ce50eb10b053962022-12-22T04:29:43ZengTaylor & Francis GroupEgyptian Journal of Anaesthesia1110-18492022-12-0138158058610.1080/11101849.2022.2132600Impact of timing of midazolam administration on incidence of postoperative nausea and vomiting in patients undergoing laparoscopic gynecological surgery: A randomized, double-blinded, controlled studySamar Rafik Amin0Taghreed Elshahat Sakr1Shaimaa Ezzat Amin2Department of Anesthesia, Faculty of Medicine, Benha University, Benha, EgyptDepartment of Anesthesia, Faculty of Medicine, Benha University, Benha, EgyptDepartment of Anesthesia, Faculty of Medicine, Benha University, Benha, EgyptBackground A frequently used anxiolytic, midazolam, has recently been recognized for its antiemetic activity during the perioperative period. This study sought to investigate the best time to provide midazolam in order to decrease the frequency of postoperative nausea and vomiting (PONV) without increasing the risk of sedation.Methods A total of 120 women aged 20–60 years who underwent laparoscopic gynecological surgeries were distributed randomly to three groups: group M1 (n = 40) received intravenous 2 mg midazolam 15 min prior anesthesia induction, group M2 (n = 40) received intravenous 2 mg midazolam approximately 30 min prior surgery conclusion, and group C (n = 40) received intravenous normal saline. The frequency of PONV and the rescue antiemetics needs were measured as the primary outcomes during the first 24 hr postoperatively. The secondary outcomes were the severity of nausea, timing of initial emetic attack, time of PACU discharge, patient sedation, and pain scores.Results The frequencies of vomiting and rescue antiemetic use were lower in midazolam groups than controls during early (0–2) and late (0–24) time periods after surgery (P < 0.05), with insignificant difference between M1 and M2 groups. The timing of the first emetic episode was significantly longer in M2 than in C groups (458.3 vs 128.8 minutes) (P < 0.01). Insignificant differences with regard to frequency and severity of nausea, time of PACU discharge, and sedation score were detected among the three groups.Conclusion Midazolam was effective in reducing PONV, whether it was given prior induction of anesthesia or prior end of surgery, without influencing recovery duration or sedation level of the patients.https://www.tandfonline.com/doi/10.1080/11101849.2022.2132600Postoperative nausea and vomitingmidazolamantiemeticslaparoscopy
spellingShingle Samar Rafik Amin
Taghreed Elshahat Sakr
Shaimaa Ezzat Amin
Impact of timing of midazolam administration on incidence of postoperative nausea and vomiting in patients undergoing laparoscopic gynecological surgery: A randomized, double-blinded, controlled study
Egyptian Journal of Anaesthesia
Postoperative nausea and vomiting
midazolam
antiemetics
laparoscopy
title Impact of timing of midazolam administration on incidence of postoperative nausea and vomiting in patients undergoing laparoscopic gynecological surgery: A randomized, double-blinded, controlled study
title_full Impact of timing of midazolam administration on incidence of postoperative nausea and vomiting in patients undergoing laparoscopic gynecological surgery: A randomized, double-blinded, controlled study
title_fullStr Impact of timing of midazolam administration on incidence of postoperative nausea and vomiting in patients undergoing laparoscopic gynecological surgery: A randomized, double-blinded, controlled study
title_full_unstemmed Impact of timing of midazolam administration on incidence of postoperative nausea and vomiting in patients undergoing laparoscopic gynecological surgery: A randomized, double-blinded, controlled study
title_short Impact of timing of midazolam administration on incidence of postoperative nausea and vomiting in patients undergoing laparoscopic gynecological surgery: A randomized, double-blinded, controlled study
title_sort impact of timing of midazolam administration on incidence of postoperative nausea and vomiting in patients undergoing laparoscopic gynecological surgery a randomized double blinded controlled study
topic Postoperative nausea and vomiting
midazolam
antiemetics
laparoscopy
url https://www.tandfonline.com/doi/10.1080/11101849.2022.2132600
work_keys_str_mv AT samarrafikamin impactoftimingofmidazolamadministrationonincidenceofpostoperativenauseaandvomitinginpatientsundergoinglaparoscopicgynecologicalsurgeryarandomizeddoubleblindedcontrolledstudy
AT taghreedelshahatsakr impactoftimingofmidazolamadministrationonincidenceofpostoperativenauseaandvomitinginpatientsundergoinglaparoscopicgynecologicalsurgeryarandomizeddoubleblindedcontrolledstudy
AT shaimaaezzatamin impactoftimingofmidazolamadministrationonincidenceofpostoperativenauseaandvomitinginpatientsundergoinglaparoscopicgynecologicalsurgeryarandomizeddoubleblindedcontrolledstudy